Eric Bjerkholt, Chief Financial Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 895 shares at $12.74 ($11K) on 2022-02-11, disclosed to the SEC on 2022-02-14.
Open-market sale of $11k KDNY by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MIRM | SELL | 2026-07-08 | $611K | — | Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-06-09 | $469K | — | Filing → |